The growth of experimental pancreatic tumours is regulated by several hormones and growth factors, not only gastrointestinal peptides (Townsend et al., 1989) , but also sex hormones (Longnecker & Sumi, 1990) , luteinising hormonereleasing hormone (LHRH) (Redding & Schally, 1984) , glucocorticoids (Benz et al., 1986) and epidermal growth factor (Malt et al., 1987) . Among the gastrointestinal peptides, cholecystokinin (CCK) and its analogues are of particular importance. In the rat and hamster, exogenous CCK and the related substance caerulein stimulate maximal pancreatic secretion and pancreatic growth when administered s.c. for 6 weeks (Barrowman & Mayston, 1974; Dembinski & Johnson, 1980) . Measures designed to increase circulating CCK levels, such as dietary administration of trypsin inhibitors or injections of cholecystokinin, appear to enhance pancreatic carcinogenesis in azaserine-treated rats (Lhoste et al., 1988; Douglas et al., 1989) , but similar studies in hamsters have given inconsistent results (Andren-Sandberg et al., 1984; Howatson & Carter, 1985; Pour et al., 1988) .
Diversion of bile and pancreatic secretions to the mid small bowel causes pancreatic hyperplasia in rats (Miazzi et al., 1987; Watanapa et al., 1991) . The associated hypercholecystokininaemia plus the inhibitory effect of the CCK anatagonist CR-1409 indicate the pivotal role of CCK in the adaptive response to pancreatobiliary diversion (PBD) . Our long-term study in rats showed that both PBD and massive small bowel resection will stimulate pancreatic growth, but only PBD enhances pancreatic carcinogenesis (Stewart et al., 1991) ; CCK levels were not measured in this experiment.
The present study was designed to test the hypothesis that hypercholecystokininaemia explains the enhancing effect of PBD on pancreatic carcinogenesis induced by azaserine in rats. We used quantitative estimation of atypical acinar cell foci (AACF) as the index of neoplastic change, in line with others (Roebuck et al., 1984; Sumi et al., 1989) , and the specific CCK antagonist CR-1409 to inhibit the response. Campbell et al. (1982) and modified by Pugh et al. (1983) . The actual numerical lower limits adopted were 0.0005 mm2 for basophilic AACF and 0.01 mm2 for the acidophilic variety; these values correspond to those chosen by Roebuck et al. (1984) . Details of this analysis have been already described in our previous studies (Stewart et al., 1991 Some pancreatic acinar cells also showed cytoplasmic vacuoles and loss of zymogen granules. These findings were not seen in the saline-treated rats.
Methods

Animal
Plasma cholecystokinin (Table II) There was a 4-fold increase in circulating CCK levels 6 months after PBD. Administration of CR-1409 had no appreciable effect on plasma hormone levels.
Quantiative analysis of AACF Acidophilic AACF, the putative precancerous lesions, were only seen in rats receiving PBD (Table III) ap < 0.001. Significance vs PBD + saline group: bp < 0.05; cp < 0.005; dp < 0.001.
By contrast, basophilic AACF occurred mainly in the sham animals (Table IV) , and the CCK antagonist had no consistent effect on their development. Although saline-treated rats had more lesions than those receiving CR-1409, the size of each focus was smaller, so that a similar percentage of the pancreas was occupied by basophilic foci.
Discussion
Our data confirm the potent effect of pancreatobiliary diversion in enhancing experimental pancreatic carcinogenesis and strongly support the hypothesis that hyperchlecystokininaemia is the key intermediary (Miazza et al., 1987; Stewart et al., 1991; Watanapa et al., 1991) . Not only were circulating CCK levels elevated after PBD, but in addition the specific antagonist CR-1409 sharply diminished the number of acidophilic AACF. These foci are now well established as the precursors of pancreatic carcinoma in this model, whereas basophilic foci appear to be of little importance. The acidophilic foci show considerable growth potential with a mitotic index (2.75) which greatly exceeds that of basophilic foci (0.125) or normal pancreas (zero) (Scarpelli et al., 1984 (Longnecker et al., 1979) , the number and size of acidophilic AACF seem to correlate positively with the incidence of carcinoma (Roebuck & Longnecker, 1977; Longnecker et al., 1981) .
The finding that PBD increases pancreatic weight as well as promoting carcinogenesis suggests that in the pancreas, as in the large intestine (Bristol et al., 1984) , hyperplasia precedes and predisposes to neoplasia. Measurements of relative and absolute wet weights are relatively crude indices of pancreatic adaptation, but the necessity of measuring AACF precluded any more sophisticated tests in the present experiment. We have previously shown that PBD causes pancreatic hyperplasia, with increased contents of RNA and DNA and increased cytokinetic indices 4 to 14 days after operation . As in the present experiment, CR-1409 inhibited the growth-promoting effect of PBD without affecting plasma CCK levels, showing that the drug probably acts as a receptor antagonist (Leung et al., 1986) . Our preliminary ultrastructural data indicate that CR-1409 causes marked vacuolation in the cytoplasm of pancreatic acinar cells, suggesting a direct toxic effect (Sarraf et al., 1990) . The inflammatory changes seen in shams with CR-1409 may explain the increased pancreatic weight in these animals, while in rats with PBD this effect was overcome by the growth stimulatory response. In line with Douglas and colleagues (1989) , our finding that CR-1409 reduced both pancreatic weight and the number of AACF supports the association between hyperplasia and neoplasia. To the contrary, one stimulus (massive enterectomy) can cause pancreatic growth without promoting cancer (Stewart et al., 1991) , while another (exogenous caerulein) can cause the reverse (Lhoste & Longnecker, 1987) . Thus the co-carcinogenic effect of PBD might be partly independent of its growth-promoting effect and could reflect a direct action of CCK on malignant transformation of the exocrine pancreas.
The development of AACF is influenced by the age of the rats at the onset of treatment . The low yield rate of acidophilic AACF in this experiment may reflect the greater age of animals used compared to other studies (4 weeks vs 19 days and 14 days) (Roebuck et al., 1985; Douglas et al., 1989) . Among saline-treated animals, the increased yield of basophilic foci in controls (as opposed to those with PBD) is of doubtful relevance since most modulators of the postinitiation phase of pancreatic carcinogenesis have little effect on these lesions (Roebuck et al., 1985) .
There are two possible explanations for the hypercholecystokininaemia that follows PBD (Miazza et al., 1987; Watanapa et al., 1991) : (1) increased CCK secretion, as diversion of pancreatobiliary secretions away from the transposed jejunum suppresses the normal negative feedback mechanism and (2) increased CCK synthesis, if the jejunal hyperplasia that follows PBD (Miazza et al., 1982; Hosomi et al., 1987) involves the enteroendocrine cells. We have previously found 2-fold elevations in circulating CCK 7-14 days after PBD , and we now find 4-fold elevations 6 months later. The progressive rise in CCK may argue more for an increased synthesis of the hormone than for perpetual interruption of feedback inhibition.
